Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study

Authors
Category Primary study
JournalEur. J. Nucl. Med. Mol. Imaging
Year 2025
This article has no abstract
Epistemonikos ID: 57e225ceba34c291f2b85470a3a7854e8345bd21
First added on: Apr 19, 2025